Liver fibrosis constitutes a critical intermediary phase in the advancement of numerous chronic liver diseases towards cirrhosis and hepatocellular carcinoma （HCC）. However， significant challenges remain in the prevention and treatment of liver fibrosis， especially in preventing its progression to cirrhosis and HCC. Unfortunately， there is currently no efficacious pharmacological intervention available for the prevention and management of liver fibrosis. Extensive longitudinal studies have substantiated the efficacy of Traditional Chinese Medicine （TCM） in the prevention and treatment of liver fibrosis. Enhancing the therapeutic efficacy of TCM in the treatment of liver fibrosis， as well as optimizing its potential to inhibit the onset and progression of liver fibrosis， cirrhosis， and HCC， continues to be a critical area of research. The therapeutic concept of "Combination Therapy with Diverse Methods and Prescriptions" was proposed as early as in "Huangdi Neijing". Building on this concept， integrating various TCM therapies to create a multi-method， multi-target treatment plan is crucial for enhancing liver fibrosis treatment efficacy. Guided by the therapeutic concept of "Combination Therapy with Diverse Methods and Prescriptions"， the multi-dimensional and systematic therapeutic approach has been consistently employed to inhibit and reverse liver fibrosis， yielding significant outcomes.